Advertisement

Digestive Diseases and Sciences

, Volume 50, Issue 3, pp 432–439 | Cite as

Helicobacter pylori Infection in Patients with Erosive Esophagitis Is Associated with Rapid Heartburn Relief and Lack of Relapse After Treatment with Pantoprazole

  • José L. Calleja
  • Manuel Suarez
  • Alberto Herreros de Tejada
  • Angel Navarro
Article

Abstract

Previous studies have shown an increased effect of proton pump inhibitors on intragastric pH in Helicobacter pylori (HP)–infected patients suffering from gastroesophageal reflux disease (GERD). We evaluated the effect of HP infection on healing and symptom relief in GERD patients with erosive esophagitis treated with pantoprazole. Two hundred twenty-seven patients with endoscopically proven reflux esophagitis were treated for 8 weeks with pantoprazole, 40 mg daily. Patients achieving endoscopic healing at that time were treated for 16 weeks more with pantoprazole, 20 mg daily. Healing and symptom relief rates for HP infection were compared. We found complete relief of heartburn in 72.3% of the HP-positive versus 58.8% of the HP-negative group (P < 0.05). Overall prevalence of heartburn at 8 weeks was higher in the HP-negative group (40.3 vs. 25.8%; P < 0.05), with no significant differences in endoscopic healing (overall 80.4%). At 24 weeks of treatment, the symptomatic relapse rate was higher in the HP-negative group (25.9 vs. 10.2%; P < 0.020). At 8 weeks, patients with erosive esophagitis and HP infection exhibited a significantly better response to pantoprazole through complete heartburn relief, with no differences in endoscopic healing rates between the groups. After 24 weeks, the relapse rate was significantly higher in the HP-negative group.

Keywords:

Helicobacter pylori erosive esophagitis GERD pantoprazole heartburn relapse gastritis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hackelsberger A, Schultze V, Gunther T: The prevalence of Helicobacter pylori gastritis in patients with reflux esophagitis: a case-control study. Eur J Gastroenterol Hepatol 10:465–468, 1998PubMedCrossRefGoogle Scholar
  2. 2.
    Wu JC, Sung JJ, Ng EK: Prevalence and distribution of Helicobacter pylori in gastresophageal reflux disease: a study from the East. Am J Gastroenterol 94:1790–1794, 1999PubMedCrossRefGoogle Scholar
  3. 3.
    Raghunath A, Hungin AP, Wooff D, Childs S: Prevalence of Helicobacter pylori in patients with gastro-esophageal reflux disease: systematic review. BMJ 5:326–337, 2003Google Scholar
  4. 4.
    Sharma P, Vakil N: Helicobacter pylori and reflux disease. Aliment Pharmacol Ther 17:297–305, 2003PubMedCrossRefGoogle Scholar
  5. 5.
    Dixon MF: Patterns of inflammation linked to ulcer disease. Baillieres Best Pract Res Clin Gastroenterol 14:27–40, 2000PubMedCrossRefGoogle Scholar
  6. 6.
    El-Omar EM, Penman ID, Ardill JE, Chittajallu RS, Howie C, McColl KE: Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 109:681–691, 1995PubMedCrossRefGoogle Scholar
  7. 7.
    Moss SF, Calam J: Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut 34:888–892, 1993PubMedCrossRefGoogle Scholar
  8. 8.
    El-Omar EM, Oien K, El-Nujumi A, et al.: Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 113:15–24, 1997PubMedCrossRefGoogle Scholar
  9. 9.
    Koike T, Ohara S, Sekine H, et al.: Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis. Am J Gastroenterol 94:3468–3472, 1999PubMedCrossRefGoogle Scholar
  10. 10.
    Gutierrez O, Melo M, Segura AM, Angel A, Genta RM, Graham DY: Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gastroenterol 32:664–668, 1997PubMedCrossRefGoogle Scholar
  11. 11.
    Haruma K, Mihara M, Okamoto E, et al.: Erradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus-evaluation of 24 hour pH monitoring Gut 45:181–185, 1998Google Scholar
  12. 12.
    El-Serag HB, Sonnenberg A, Jamal MM, Inadomi JM, Crooks LA, Feddersen RM: Corpus gastritis is protective against reflux esophagitis. Gut 45:181–185, 1999PubMedCrossRefGoogle Scholar
  13. 13.
    Koike T, Ohara S, Sekine H, et al.: Helicobacter pylori infection prevents erosive reflux esophagitis by decreasing gastric acid secretion. Gut 49:330–334, 2001PubMedCrossRefGoogle Scholar
  14. 14.
    Gillen D, Wirz AA, Neithercut WD, Ardill JE, McColl KE: Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole. Gut 44:468–475, 1999PubMedCrossRefGoogle Scholar
  15. 15.
    Moayyedi P, Wason C, Peacock R, et al.: Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression. Helicobacter 5:206–2014, 2000PubMedCrossRefGoogle Scholar
  16. 16.
    Wu JC, Chan FK, Ching JY, et al.: Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial. Gut 53:174–179, 2004PubMedCrossRefGoogle Scholar
  17. 17.
    Rokkas T, Ladas SD, Triantafyllou K, et al.: The association between CagA status and the development of esophagitis after the eradication of Helicobacter pylori. Am J Med 110:703–707, 2001PubMedCrossRefGoogle Scholar
  18. 18.
    Bercik P, Verdu E, Armstrong D, et al.: The effect of ammonia on omeprazole-induced reduction of gastric acidity in subjects with Helicobacter infection. Am J Gastroenterol 95:947–955, 2000PubMedGoogle Scholar
  19. 19.
    Wu JC, Chan FK, Wong SK, Lee YT, Leung WK, Sung JJ: Effect of Helicobacter pylori eradication on esophageal acid exposure inpatients with reflux esophagitis. Aliment Pharmacol Ther 16:545–552, 2002PubMedCrossRefGoogle Scholar
  20. 20.
    Manifold DK, Anggiansah A, Rowe I, Sanderson JD, Chinyama CN, Owen WJ: Gastro-esophageal reflux and duodenogastric reflux before and after eradication in Helicobacter pylori gastritis. Eur J Gastroenterol Hepatol 13:535–539, 2001PubMedCrossRefGoogle Scholar
  21. 21.
    Tefera S, Hatlebakk JG, Berstad A: The effect of Helicobacter pylori eradication on gastro-esophageal reflux. Aliment Pharmacol Ther 13:915–920, 1999PubMedCrossRefGoogle Scholar
  22. 22.
    Schwizer W, Thumshirn M, Dent J, et al.: Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial. Lancet 357:1738–1742, 2001. Erratum: Lancet 358:1734, 2000PubMedCrossRefGoogle Scholar
  23. 23.
    Moayyedi P, Bardhan C, Young L, Dixon MF, Brown L, Axon AT: Helicobacter pylori eradication does not exacerbate reflux symptoms in gastresophageal reflux disease. Gastroenterology 121:1120–1126, 2001PubMedCrossRefGoogle Scholar
  24. 24.
    Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G: Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 112:1442–1447, 1997PubMedCrossRefGoogle Scholar
  25. 25.
    Hamada H, Haruma K, Mihara M, et al.: High incidence of reflux esophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther 14:729–735, 2000PubMedCrossRefGoogle Scholar
  26. 26.
    Fallone CA, Barkun AN, Friedman G, et al.: Is Helicobacter pylori eradication associated with gastresophageal reflux disease? Am J Gastroenterol 95:914–920, 2000PubMedCrossRefGoogle Scholar
  27. 27.
    Miwa H, Sugiyama Y, Ohkusa T, et al.: Improvement of reflux symptoms 3 years after cure of Helicobacter pylori infection: a case-controlled study in the Japanese population. Helicobacter 7:219–224, 2002PubMedCrossRefGoogle Scholar
  28. 28.
    Malfertheiner P, Dent J, Zeijlon L, et al.: Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease—Results from a randomized trial programme. Aliment Pharmacol Ther 16:1431–1442, 2002PubMedCrossRefGoogle Scholar
  29. 29.
    Labenz J, Tillenburg B, Peitz U, et al.: Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 110:725–732, 1996PubMedCrossRefGoogle Scholar
  30. 30.
    Loffeld RJ, van der Hulst RW: Helicobacter pylori and gastro-esophageal reflux disease: association and clinical implications. To treat or not to treat with anti-H. pylori therapy? Scand J Gastroenterol Suppl 236:15–18, 2002PubMedGoogle Scholar
  31. 31.
    Holtmann G, Cain C, Malfertheiner P: Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. Gastroenterology 117:11–16, 1999PubMedCrossRefGoogle Scholar
  32. 32.
    Meneghelli UG, Boaventura S, Moraes-Filho JP, et al.: Efficacy and tolerability of pantoprazole versus ranitidine in the treatment of reflux esophagitis and the influence of Helicobacter pylori infection on healing rate. Dis Esophagus 15:50–56, 2002PubMedCrossRefGoogle Scholar
  33. 33.
    Vakil N, Kahrilas P, Magner D, et al.: Does baseline H. pylori status impact erosive esophagitis healing rates? Am J Gastroenterol 95:2438, 2000CrossRefGoogle Scholar
  34. 34.
    Vakil N, Zuckerman S, Levine J: H. pylori infection and the severity of esophagitis and healing with lansoprazole and esomeprazole. Gastroenterology 122:A-199, 2002Google Scholar
  35. 35.
    Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Eskes SA, Meuwissen SG: Helicobacter pylori and the efficacy of omeprazole therapy for gastresophageal reflux disease. Am J Gastroenterol 94:884–887, 1999PubMedCrossRefGoogle Scholar
  36. 36.
    Ollyo JB, Fontolliet Ch, Brossard E, et al.: La nouvelle classification de Savary des oesophagites de reflux. Acta Endosc 22:307–320, 1992CrossRefGoogle Scholar
  37. 37.
    Armstrong D, Monnier P, Nicolet M, et al.: Endoscopic assessment of esophagitis. Gullet 1:63–67, 1991Google Scholar
  38. 38.
    Ollyo JB, Lang F, Fontolliet C, Monnier O: Savary–Miller’s new endoscopic grading of reflux-oesophagitis: a simple, reproductible, logical, complete and useful classification. Gastroenterology 98:A100, 1990Google Scholar
  39. 39.
    Svedlund J, Sjodin I, Dotevall G: GSRS—A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 33:129–134, 1988PubMedCrossRefGoogle Scholar
  40. 40.
    Revicki DA, Wood M, Wiklund I, Crawley J: Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 7:75–83, 1998PubMedCrossRefGoogle Scholar
  41. 41.
    Martin de Argila C, Boixeda D, Cantón R, et al.: Helicobacter pylori infection in a healthy population in Spain. Eur J Gastroenterol Hepatol 8:1165–1168, 1996PubMedCrossRefGoogle Scholar
  42. 42.
    Metz DC, Bochenek WJ: Pantoprazole US GERD Study Group. Pantoprazole maintenance therapy prevents relapse of erosive esophagitis. Aliment Pharmacol Ther 17:155–164, 2003PubMedCrossRefGoogle Scholar
  43. 43.
    Carlsson R, Bate C, Dent J: Does H. pylori infection influence in the response to treatment with acid inhibition in patients with GERD? Scand J Gastroenterol 32 (Suppl 224):F70, 1997Google Scholar
  44. 44.
    Vakil N: Gastresophageal reflux disease and Helicobacter pylori infection. Rev Gastroenterol Disord 3:1–7, 2003PubMedGoogle Scholar
  45. 45.
    Malfertheiner P, Megraud F, O’Morain C, et al.: Current concepts in the management of Helicobacter pylori infection—The Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 16:167–180, 2002CrossRefPubMedGoogle Scholar
  46. 46.
    Armstrong D, Bennett JR, Blum AL, et al.: Gastroenterology 111:85–92, 1996PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • José L. Calleja
    • 2
    • 3
  • Manuel Suarez
    • 1
  • Alberto Herreros de Tejada
    • 2
  • Angel Navarro
    • 3
  1. 1.Recordati España, Scientific Research DepartmentHospital Universitario Juan CanalejoLa Coruña
  2. 2.Pantogerd GroupSpain
  3. 3.Servicio de GastroenterologíaHospital Universitario Puerta de HierroMadridSpain

Personalised recommendations